MetaADEDB 2.0 @ LMMD
Doxepin
(ODQWQRRAPPTVAG-UHFFFAOYSA-N)
Structure
SMILES
CN(CCC=C1c2ccccc2OCc2c1cccc2)C
Type(s)
Approved; Investigational
ATC code(s)
D04AX01; N06AA12
Molecular Formula:
C19H21NO
Molecular Weight:
279.376
Log P:
3.9624
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
0
TPSA:
12.47
CAS Number(s):
1668-19-5
Synonym(s)
1.
Doxepin
2.
Apo-Doxepin
3.
Aponal
4.
Deptran
5.
Desidox
6.
Doneurin
7.
Doxepia
8.
Doxepin Hydrochloride
9.
Doxepin Hydrochloride, Cis-Trans Isomer Mixture (approximately 1:5)
10.
Doxepin beta
11.
Doxepin-RPh
12.
Espadox
13.
Mareen
14.
Novo-Doxepin
15.
Prudoxin
16.
Quitaxon
17.
Sinequan
18.
Sinquan
19.
Xepin
20.
Zonalon
21.
Apo Doxepin
22.
ApoDoxepin
23.
Doxepin RPh
24.
Hydrochloride, Doxepin
25.
Novo Doxepin
External Link(s)
MeSHD004316
PubChem Compound3158
667468
BindingDB50225488
ChEBI4710
CHEMBLCHEMBL1628227
DrugBankDB01142
DrugCentral956
KEGGcpd:C06971
dr:D07875
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1ErythemaFAERS: 3US FAERS
2PruritusFAERS: 3US FAERS
3Burning sensationFAERS: 2US FAERS
4PainFAERS: 2US FAERS
5Product use in unapproved indicationFAERS: 2US FAERS
6SwellingFAERS: 2US FAERS
7Therapeutic response unexpectedFAERS: 2US FAERS
8Thermal burnFAERS: 2US FAERS
9DiscomfortFAERS: 1US FAERS
10DizzinessFAERS: 1US FAERS
11Dry skinFAERS: 1US FAERS
12Impaired driving abilityFAERS: 1US FAERS
13Incorrect drug administration durationFAERS: 1US FAERS
14Intentional product misuseFAERS: 1US FAERS
15NauseaFAERS: 1US FAERS
16Pain of skinFAERS: 1US FAERS
17Product use issueFAERS: 1US FAERS
18VertigoFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120242

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.